The association of perceived cannabis risks and benefits with cannabis use since cancer diagnosis.

Autor:	McDaniels-Davidson C; Division of Health Promotion and Behavioral Science, School of Public Health, San Diego State University, San Diego, CA, USA.; Moores Cancer Center at UC San Diego Health, La Jolla, CA, USA., Parada H Jr; Moores Cancer Center at UC San Diego Health, La Jolla, CA, USA.; Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, CA, USA., Kasiri N; Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, CA, USA., Patel SP; Moores Cancer Center at UC San Diego Health, La Jolla, CA, USA., Strong D; Moores Cancer Center at UC San Diego Health, La Jolla, CA, USA.; Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego,La Jolla, CA, USA., Doran N; Moores Cancer Center at UC San Diego Health, La Jolla, CA, USA.; Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA.; Psychology Service, Jennifer Moreno Department of Veterans Affairs Medical Center, San Diego, CA, USA.
Jazyk:	angličtina
Zdroj:	Journal of the National Cancer Institute. Monographs [J Natl Cancer Inst Monogr] 2024 Aug 15; Vol. 2024 (66), pp. 244-251.
DOI:	10.1093/jncimonographs/lgad024
Abstrakt:	Background: Many patients with cancer use cannabis to help alleviate untreated cancer symptoms and side effects. Methods: We examined associations of perceived benefits and risks and postdiagnosis cannabis use in a weighted sample of adult cancer survivors through a 1-time survey. Fifteen perceived cannabis use benefits and 19 perceived risks were operationalized as both summary scores and report of any benefits or risks. Survey-weighted logistic regression provided covariate-adjusted odds of postdiagnosis cannabis use for each benefit-risk measure. Results: Among the weighted population of 3785 survivors (mean [SD] age = 62.2 [13.5] years), one-third used cannabis after diagnosis. Perceiving any benefits increased the odds of postdiagnosis cannabis use more than 500%, and perceiving any risks lowered the odds by 59%. Each SD increase in endorsed benefits doubled the odds of postdiagnosis cannabis use, while each SD increase in endorsed risks reduced the odds by 36%. Conclusion: An accurate understanding of benefits and risks is critical for informed decision making. (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu